These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12207104)

  • 21. [Risk of type 2 diabetes mellitus among users of atypical antipsychotic drugs or conventional treatment: systematic review and meta-analysis].
    Sapunar Z J; Muñoz N S; Vásquez A T
    Rev Med Chil; 2009 Nov; 137(11):1417-26. PubMed ID: 20098798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes mellitus associated with atypical antipsychotic medications: new case report and review of the literature.
    Muench J; Carey M
    J Am Board Fam Pract; 2001; 14(4):278-82. PubMed ID: 11458971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risperidone alternative for a schizophrenic patient with olanzapine-exacerbated diabetic mellitus.
    Wu PL; Lane HY; Su KP
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):115-6. PubMed ID: 16472369
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of age, family history of diabetes, and antipsychotic drug treatment on risk of diabetes in people with psychosis: a population-based cross-sectional study.
    Foley DL; Mackinnon A; Morgan VA; Watts GF; Castle DJ; Waterreus A; Galletly CA
    Lancet Psychiatry; 2015 Dec; 2(12):1092-8. PubMed ID: 26477242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes mellitus associated with atypical anti-psychotic medications.
    Clark C; Burge MR
    Diabetes Technol Ther; 2003; 5(4):669-83. PubMed ID: 14511422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The metabolic effects of antipsychotic medications.
    Newcomer JW; Haupt DW
    Can J Psychiatry; 2006 Jul; 51(8):480-91. PubMed ID: 16933585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Newer antipsychotics and glucose metabolism: a comparison between olanzapine and risperidone.
    Filaković P; Laufer D; Radanović-Grgurić L; Koić O; Fijacko M; Durković M
    Psychiatr Danub; 2005 Jun; 17(1-2):63-6. PubMed ID: 16395845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-resistant hyperglycemia induced by clozapine.
    Isakov I; Klesmer J; Masand PS
    Psychosomatics; 2000; 41(4):373-4. PubMed ID: 10906368
    [No Abstract]   [Full Text] [Related]  

  • 30. Clozapine-induced type-2 diabetes mellitus: possible mechanisms and implications for clinical practice.
    Tovey E; Rampes H; Livingstone C
    J Psychopharmacol; 2005 Mar; 19(2):207-10. PubMed ID: 15728442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence?
    Henderson DC
    CNS Drugs; 2002; 16(2):77-89. PubMed ID: 11825099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature.
    Cohen D
    Pharmacopsychiatry; 2004 Jan; 37(1):1-11. PubMed ID: 14750042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.
    Lerner V; Libov I; Kotler M; Strous RD
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):89-98. PubMed ID: 14687862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risperidone-associated diabetes mellitus: a pharmacovigilance study.
    Koller EA; Cross JT; Doraiswamy PM; Schneider BS
    Pharmacotherapy; 2003 Jun; 23(6):735-44. PubMed ID: 12820816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antipsychotic drug-induced changes in metabolism].
    Engl J; Tschoner A; Laimer M; Rettenbacher M; Wolfgang Fleischhacker W; Patsch JR; Ebenbichler C
    Wien Klin Wochenschr; 2006 May; 118(7-8):196-206. PubMed ID: 16794755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diabetes in treatment with antipsychotic drugs: who is at risk]].
    Deuschle M
    MMW Fortschr Med; 2005 Dec; 147(51-52):34. PubMed ID: 16402705
    [No Abstract]   [Full Text] [Related]  

  • 38. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.
    Leslie DL; Rosenheck RA
    Am J Psychiatry; 2004 Sep; 161(9):1709-11. PubMed ID: 15337666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical antipsychotics and glucose dysregulation: a systematic review.
    Jin H; Meyer JM; Jeste DV
    Schizophr Res; 2004 Dec; 71(2-3):195-212. PubMed ID: 15474892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes.
    Lean ME; Pajonk FG
    Diabetes Care; 2003 May; 26(5):1597-605. PubMed ID: 12716824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.